Scanning the horizon for high value-add manufacturing science: Accelerating manufacturing readiness for the next generation of disruptive, high-value curative cell therapeutics.

Hourd, Paul; Williams, David J

Hourd, Paul; Williams, David J.

Afiliação

Hourd P; Wolfson School for Mechanical, Electrical and Manufacturing Engineering, Centre for Biological Engineering, Loughborough University, Leicestershire, United Kingdom.
Williams DJ; Wolfson School for Mechanical, Electrical and Manufacturing Engineering, Centre for Biological Engineering, Loughborough University, Leicestershire, United Kingdom. Electronic address: D.J.Williams2@lboro.ac.uk.

Cytotherapy ; 20(5): 759-767, 2018 05.

Article em En | MEDLINE | ID: mdl-29673565

Assuntos

Terapia Baseada em Transplante de Células e Tecidos/métodos; Diferenciação Celular; Proliferação de Células; Edição de Genes; Humanos; Células-Tronco Pluripotentes Induzidas/citologia

Palavras-chave

disruptive; gene editing; induced pluripotent stem cells; manufacturing readiness; manufacturing science; regenerative medicine; technology readiness

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Baseada em Transplante de Células e Tecidos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google